scispace - formally typeset
P

Patric J.D. Delhanty

Researcher at Erasmus University Rotterdam

Publications -  54
Citations -  2453

Patric J.D. Delhanty is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Ghrelin & Internal medicine. The author has an hindex of 24, co-authored 48 publications receiving 2120 citations. Previous affiliations of Patric J.D. Delhanty include Erasmus University Medical Center.

Papers
More filters
Journal ArticleDOI

Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes

TL;DR: Gl glucose output by primary hepatocytes is time- and dose-dependently stimulated by AG and inhibited by UAG, and UAG counteracts the stimulatory effect of AG on glucose release.
Journal ArticleDOI

Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity.

TL;DR: This combined administration of acylated and unacylated ghrelin even significantly improved insulin sensitivity, compared with placebo, for at least 6 h, which warrants studies to investigate the long-term efficacy of this combination in the treatment of disorders with disturbed insulin sensitivity.
Journal ArticleDOI

Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a

TL;DR: Overall,ghrelin gene expression was greater in differentiating than non-differentiating osteoblasts, but was not increased during culture in either group, suggesting new roles for ghrelin and UAG in modulating human osteoblast proliferation via a novel signal transduction pathway.
Journal ArticleDOI

Unacylated Ghrelin Rapidly Modulates Lipogenic and Insulin Signaling Pathway Gene Expression in Metabolically Active Tissues of GHSR Deleted Mice

TL;DR: UAG rapidly modulates the expression of metabolically important genes in fat, muscle and liver of growth hormone secretagogue receptor-deleted mice indicating a direct, GHSR-independent, action of UAG to improve insulin sensitivity and metabolic profile.